Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about ARENA PHARMACEUTICALS, INC
04/27 INSIDER TRADING ACTIVITY ARENA PHARM : ARNA) – Insider Bought 50,000 share..
04/21 ARENA PHARMACEUTICALS : Announces Completion of Public Offering of Common Stock ..
04/18 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) Files An 8-K Other Events
04/18 ARENA PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
04/17 ARENA PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
04/17 ARENA PHARMACEUTICALS : Announces Multiple Presentations at ASPET 2017 at Experi..
04/13 ARENA PHARMACEUTICALS : Biotech Stocks on Investors' Radar -- Halozyme Therapeut..
03/27 ARENA PHARMACEUTICALS : to Present at the 16th Annual Needham Healthcare Confere..
03/20 ARENA PHARMACEUTICALS : Appoints Dr. Preston Klassen, M.D., M.H.S. as Executive ..
03/15 ARENA PHARMACEUTICALS : ARNA) Jumps on Q4 Earnings
03/14 ARENA PHARMACEUTICALS : beats 4Q profit forecasts
03/14 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Fourth Quarter and..
03/08 ARENA PHARMACEUTICALS : to Present at the 27th Annual Oppenheimer Healthcare Con..
03/06 Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter ..
02/14 ARENA PHARMACEUTICALS : Appoints Three New Members to Board of Directors
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
04/27 ARENA PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
04/27 INSIDER TRADING ACTIVITY ARENA PHARM : ARNA) – Insider Bought 50,000 share..
04/21 ARENA PHARMACEUTICALS : Announces Completion of Public Offering of Common Stock ..
04/19 ARENA PHARMACEUTICALS, INC. : Biotech Industry Outperforming Major Indexes in 20..
04/18 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) Files An 8-K Other Events
04/18 ARENA PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (for..
04/18 ARENA PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
04/17 ARENA PHARMACEUTICALS INC : Results of Operations and Financial Condition, Other..
04/17 ARENA PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
04/17 ARENA PHARMACEUTICALS : Announces Multiple Presentations at ASPET 2017 at Experi..
More news
Sector news : Biotechnology & Medical Research - NEC
04/28 REGENERON PHARMACEUTICALS : Sanofi beats profit forecasts, upbeat on prospects f..
04/28DJSanofi 1st-Quarter Net Profit Rises on Sale of Animal-Health Unit
04/27 AMGEN : Cost controls help offset lower Amgen first-quarter drug sales
04/26 New GlaxoSmithKline CEO wants fewer, bigger new drug launches
04/18 Johnson & Johnson first quarter revenue misses estimates; new forecast includ..
04/18DJACTELION : J&J Lifts Forecast on Actelion Tie-Up--Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
04/18 ARENA PHARMA : Secondary Offering $69M - How Low Will It Go?
04/18 Midday Gainers / Losers
04/18 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
04/18 PREMARKET LOSERS AS OF 9 : 05 am
04/18 Arena Pharmaceuticals prices equity offering; shares slip 19% premarket
04/17 Arena Pharma preparing equity offering; shares slump 17% after hours
Latest Tweets
04/22Here’s Why Arena Pharmaceuticals, Inc. (ARNA) Shares Are Lower  
04/19Arena Pharma: Secondary Offering $69M - How Low Will It Go? $ARNA  
04/19Arena Pharma: Secondary Offering $69M - How Low Will It Go?  
04/18Here’s Why $ARNA Shares Are Lower  
04/18Here’s What You Should Know About The Finance World Today $CAH $KATE $ARNA $I.. 
More tweets
Qtime:31
Advertisement
Financials ($)
Sales 2017 33,2 M
EBIT 2017 -61,6 M
Net income 2017 -67,4 M
Finance 2017 31,0 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 11,5x
EV / Sales 2018 14,4x
Capitalization 412 M
More Financials
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Full-screen chart
Technical analysis trends ARENA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 3,25 $
Spread / Average Target 143%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Amit D. Munshi President, Chief Executive Officer & Director
Tina Susan Nova Chairman
Craig M. Audet SVP-Operations & Head-Global Regulatory Affairs
Kevin R. Lind Chief Financial Officer & Executive Vice President
John Adams Head-Scientific Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS,..-5.63%412
INCYTE CORPORATION23.95%25 426
QUINTILES IMS HOLDINGS..10.82%19 884
LONZA GROUP AG17.13%11 836
SEATTLE GENETICS, INC.29.43%9 741
CELLTRION, INC.--.--%9 653
More Results